Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Body composition in chemotherapy: the promising role of CT scans.
Prado CM. Prado CM. Curr Opin Clin Nutr Metab Care. 2013 Sep;16(5):525-33. doi: 10.1097/MCO.0b013e328363bcfb. Curr Opin Clin Nutr Metab Care. 2013. PMID: 23799328 Review.
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer.
Prado CM, Baracos VE, Xiao J, Birdsell L, Stuyckens K, Park YC, Parekh T, Sawyer MB. Prado CM, et al. Appl Physiol Nutr Metab. 2014 Jun;39(6):693-8. doi: 10.1139/apnm-2013-0403. Epub 2014 Jan 23. Appl Physiol Nutr Metab. 2014. PMID: 24869973 Clinical Trial.
A population-based approach to define body-composition phenotypes.
Prado CM, Siervo M, Mire E, Heymsfield SB, Stephan BC, Broyles S, Smith SR, Wells JC, Katzmarzyk PT. Prado CM, et al. Am J Clin Nutr. 2014 Jun;99(6):1369-77. doi: 10.3945/ajcn.113.078576. Epub 2014 Apr 23. Am J Clin Nutr. 2014. PMID: 24760978
Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR, Sawyer MB. Meza-Junco J, et al. J Clin Gastroenterol. 2013 Nov-Dec;47(10):861-70. doi: 10.1097/MCG.0b013e318293a825. J Clin Gastroenterol. 2013. PMID: 23751844
Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity.
Prado CM, Antoun S, Sawyer MB, Baracos VE. Prado CM, et al. Curr Opin Clin Nutr Metab Care. 2011 May;14(3):250-4. doi: 10.1097/MCO.0b013e3283455d45. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21415735 Review.
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.
Prado CM, Lima IS, Baracos VE, Bies RR, McCargar LJ, Reiman T, Mackey JR, Kuzma M, Damaraju VL, Sawyer MB. Prado CM, et al. Cancer Chemother Pharmacol. 2011 Jan;67(1):93-101. doi: 10.1007/s00280-010-1288-y. Epub 2010 Mar 5. Cancer Chemother Pharmacol. 2011. PMID: 20204364 Clinical Trial.
The emerging role of computerized tomography in assessing cancer cachexia.
Prado CM, Birdsell LA, Baracos VE. Prado CM, et al. Curr Opin Support Palliat Care. 2009 Dec;3(4):269-75. doi: 10.1097/SPC.0b013e328331124a. Curr Opin Support Palliat Care. 2009. PMID: 19667996 Review.
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Prado CM, et al. Clin Cancer Res. 2009 Apr 15;15(8):2920-6. doi: 10.1158/1078-0432.CCR-08-2242. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351764
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prado CM, et al. Lancet Oncol. 2008 Jul;9(7):629-35. doi: 10.1016/S1470-2045(08)70153-0. Epub 2008 Jun 6. Lancet Oncol. 2008. PMID: 18539529
252 results
Jump to page
Feedback